Keyphrases
Arbitrary PCR
15%
Blood Samples
15%
Cancer Prognosis
15%
Cancer Risk
22%
Circulating Tumor Cells
15%
Colorectal Cancer
87%
Colorectal Cancer Patients
20%
Colorectal Cancer Risk
20%
Epimutation
17%
Familial Colorectal Cancer
18%
Genetic Diagnosis
16%
Genetic Testing
28%
Germ Cells
28%
Germline mutation
46%
Hereditary Cancer
18%
Hereditary Cancer Syndromes
14%
Hereditary Colorectal Cancer Syndromes
25%
Immunohistochemistry
22%
In Cancer
22%
KRAS mutation
15%
Lynch Syndrome
100%
Lynch-like
31%
Methylation
18%
Methylation Analysis
17%
Microsatellite Instability-high (MSI-H)
23%
Mismatch Repair
21%
Mismatch Repair Genes
20%
MLH1
65%
MLH1 Methylation
17%
Molecular Characterization
19%
MSH6
19%
Multidrug Resistance Protein 1 (MDR1)
15%
Multimarker
15%
MUTYH
15%
Neoplasia
15%
Next-generation Sequencing
19%
Non-muscle Invasive Bladder Cancer (NMIBC)
15%
Patients with Colorectal Cancer
16%
POLD1
23%
Polymer-based
21%
Polyposis
19%
Polyps
22%
Risk Factors
16%
Serrated Polyps
18%
SNP
14%
Spanish Population
27%
TGFBR1
23%
Tumor
56%
Tumor Cells
27%
Ultrasound
22%
Biochemistry, Genetics and Molecular Biology
Allele
22%
Cancer Cell
7%
Carcinogenesis
8%
Case-Control Study
19%
Clinical Classification
7%
Colon
13%
DNA Methylation
15%
DNA Mismatch Repair
58%
DNA Profiling
9%
DNA Repair
7%
Drug Resistance
9%
Epigenetics
12%
Epimutation
24%
Exon
12%
Gene Mutation
13%
Gene Repair
14%
Genetic Divergence
23%
Genetic Screening
25%
Genetics
49%
Germ Cell
37%
Germline
33%
Germline Mutation
41%
Haplotype
16%
Karyotype
9%
KRAS
12%
Methylation
37%
Microsatellite Instability
25%
Missense
15%
MLH1
72%
Mosaicism
9%
MSH2
27%
MSH6
22%
MUTYH
17%
Next Generation Sequencing
36%
Normal Human
7%
Oncogene
8%
P16
7%
Penetrance
17%
PMS2
15%
Polymerase
7%
Prevalence
37%
Proband
12%
Promoter Region
9%
Risk Reduction
7%
Signal Transduction
8%
Single Nucleotide Polymorphism
16%
Single-Nucleotide Polymorphism
9%
Transforming Growth Factor Beta
13%
Tumor Gene
8%
Tumor Progression
11%
Medicine and Dentistry
Angiopeptin
7%
Cancer Prognosis
7%
Cancer Therapy
7%
Circulating Tumor Cell
11%
Cisplatin
7%
Clinical Genetics
7%
Clinical Guideline
7%
Colon Polyp
14%
Colorectal Carcinoma
66%
Colorectal Tumor
9%
Dacarbazine
7%
Disease
21%
DNA Mismatch Repair
35%
Drug Megadose
7%
Drug Resistance
8%
Exocrine Pancreatic Cancer
11%
Exon
5%
Familial Cancer
8%
Gene Mutation
5%
Gene Repair
13%
Genetic Screening
5%
Germ Cell
9%
Germline Mutation
27%
Hereditary Colorectal Cancer
26%
Hereditary Nonpolyposis Colorectal Cancer
44%
Immunohistochemistry
10%
Lung Cancer
7%
Malignant Neoplasm
28%
Methylation
8%
Microsatellite Instability
7%
Neoplasm
35%
Next Generation Sequencing
7%
Non Muscle Invasive Bladder Cancer
15%
Pancreas Cancer
9%
Paraganglioma
7%
Polymerase
7%
Polyp
31%
Polyposis
34%
Prevalence
25%
Primary Tumor
5%
Recurrent Disease
6%
Risk Reduction
7%
Single Nucleotide Polymorphism
15%
Skin Metastasis
7%
Somatic Mutation
9%
Southern District Health Board
7%
Standardized Incidence Ratio
10%
Tumor Cell
10%
Vinblastine
7%
